TRIP12 and neoplasm: Khan et al. revealed that the HECT-domain in the E3 ubiquitin ligase TRIP12 is indispensable for proteasomal degradation of the tumour suppressor FBW7 to sensitise cells to Taxol chemotherapy [37].